The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a better treatment for avoiding surgery, preserving the rectum and anus, and preventing regrowth of the primary tumor than a short course of radiotherapy for patients with rectal cancer – a type of bowel cancer.
Oncolytic virus startup Calidi secures $25M toward Series B round
Calidi Biotherapeutics, a San Diego biotech working on developing allogeneic cell delivery of oncolytic viruses, said Friday that investors have committed $25 million to a
June 24, 2023